Literature DB >> 24622427

Comparison of two and three dimensional quantitative coronary angiography to intravascular ultrasound in the assessment of left main coronary artery bifurcation lesions.

Jing Kan1, Xiaofei Gao1, Kumar Gami Sandeep1, Haimei Xu1, Yingying Zhao1, Shaoliang Chen1, Feng Chen2.   

Abstract

BACKGROUND: Angiographic evaluation of left main coronary artery (LMCA) bifurcation lesions is often limited. two dimensional (2D) quantitative coronary angiography (QCA) with segmental analysis provides accuracy for quantification of the degree of stenosis in the main vessel and side branch ostium but can be affected by foreshortening and variable magnification. The accuracy of three dimensional (3D) QCA has recently developed to overcome 2D QCA limitations, however, accuracy and precision of 3D bifurcation QCA measurements in LMCA bifurcation lesions has not been established.
METHODS: We investigated whether such 3D and 2D bifurcation QCA measurements differ in their accuracy in assessing significant LMCA bifurcation lesions defined by intravascular ultrasound (IVUS) as a minimum luminal area (MLA) <6 mm(2) of LMCA and MLA <4 mm(2) of proximal left anterior descending (LAD) and/or proximal left circumflex (LCX)
RESULTS: LMCA bifurcation lesions were assessed in 44 patients undergoing elective percutaneous coronary intervention. From 2D QCA measurements, MLA correlated moderately with threshold intravascular ultrasound MLA for LMCA (r = 0.81, P < 0.000 1), LAD (r = 0.54, P = 0.000 1) and LCX (r = 0.58, P < 0.000 1). Severity of lesion as MLA by derived 3D QCA, correlated moderately with threshold intravascular ultrasound MLA for LMCA (r = 0.84, P < 0.000 1), LAD (r = 0.53, P = 0.000 2); LCX (r = 0.66, P < 0.000 1). Overall, the C statistics tended to be slightly higher for 3D QCA and 2D QCA measurements in LMCA segment compared with proximal LAD and LCX segments, and there were no significant predictive power of percent diameter stenosis and percent area stenosis on 3D QCA for LCX IVUS MLA <4 mm(2) (percent diameter stenosis: area under curve 0.55, cutoff 23%, sensitivity 88%, specificity 37%, P = 0.618 6; percent arer stenosis: area under curve 0.56, cutoff 41%, sensitivity 83%, specificity 38%, P = 0.518 4, respectively).
CONCLUSIONS: The accuracy of 3D bifurcation QCA in detecting significant LMCA bifurcation lesions is limited, especially the proximal LCX ostium. When IVUS is not available or contraindicated, 3D QCA may assist in the evaluation of intermediate LMCA lesions with MLA.

Entities:  

Mesh:

Year:  2014        PMID: 24622427

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

1.  Safety and efficacy of a novel technique in the use of fractional flow reserve in complex coronary artery lesions.

Authors:  Wen-Ming He; Chang-Ling Li; Yong Sun; Zhong Zhou; Yi-Feng Mai
Journal:  Chin Med J (Engl)       Date:  2015-03-20       Impact factor: 2.628

2.  Comparison of coronary arterial lumen dimensions on angiography and plaque characteristics on optical coherence tomography images and their changes induced by statin.

Authors:  Nana Dong; Zulong Xie; Wei Wang; Jiannan Dai; Meng Sun; Zhongyue Pu; Jinwei Tian; Bo Yu
Journal:  BMC Med Imaging       Date:  2016-11-22       Impact factor: 1.930

3.  3D reconstruction of coronary artery bifurcations from coronary angiography and optical coherence tomography: feasibility, validation, and reproducibility.

Authors:  Wei Wu; Saurabhi Samant; Gijs de Zwart; Shijia Zhao; Behram Khan; Mansoor Ahmad; Marco Bologna; Yusuke Watanabe; Yoshinobu Murasato; Francesco Burzotta; Emmanouil S Brilakis; George Dangas; Yves Louvard; Goran Stankovic; Ghassan S Kassab; Francesco Migliavacca; Claudio Chiastra; Yiannis S Chatzizisis
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

Review 4.  Physiology-Based Revascularization of Left Main Coronary Artery Disease.

Authors:  Peter Kayaert; Mathieu Coeman; Sofie Gevaert; Michel De Pauw; Steven Haine
Journal:  J Interv Cardiol       Date:  2021-02-10       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.